Qingchun Zeng

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

Experimental & molecular medicine

Molecular medicine (Cambridge, Mass.)

Therapeutic advances in chronic disease

Oxidative medicine and cellular longevity

University of Colorado Denver

Southern Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Colorado Denver Jul 08 2010 - Aug 01 2014

United States

Research fellow :: Cardiothoracic Surgery

Education History

Southern Medical University Sep 01 2009 - Jun 30 2013

China

PHD

Publications

Gaopeng Xian, Rong Huang, Minhui Xu, Hengli Zhao, Xingbo Xu, Yangchao Chen, Hao Ren, Dingli Xu, Qingchun Zeng
Noncoding RNA regulates the expression of Krm1 and Dkk2 to synergistically affect aortic valve lesions. Experimental & molecular medicine (2024)
Xi Yang, Jingxin Zeng, Kaiji Xie, Shuwen Su, Yuyang Guo, Hao Zhang, Jun Chen, Zhuang Ma, Zezhou Xiao, Peng Zhu, Shaoyi Zheng, Dingli Xu, Qingchun Zeng
Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE/NF-κB pathway and exaggerates aortic valve calcification in hamsters. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Gaopeng Xian, Rong Huang, Minhui Xu, Hengli Zhao, Xingbo Xu, Yangchao Chen, Hao Ren, Dingli Xu, Qingchun Zeng
Noncoding RNA regulates the expression of Krm1 and Dkk2 to synergistically affect aortic valve lesions. Experimental & molecular medicine 56 (7) (2024)
Xi Yang, Jingxin Zeng, Kaiji Xie, Shuwen Su, Yuyang Guo, Hao Zhang, Jun Chen, Zhuang Ma, Zezhou Xiao, Peng Zhu, Shaoyi Zheng, Dingli Xu, Qingchun Zeng
Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE/NF-κB pathway and exaggerates aortic valve calcification in hamsters. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Xi Yang, Jingxin Zeng, Kaiji Xie, Shuwen Su, Yuyang Guo, Hao Zhang, Jun Chen, Zhuang Ma, Zezhou Xiao, Peng Zhu, Shaoyi Zheng, Dingli Xu, Qingchun Zeng
Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE/NF-κB pathway and exaggerates aortic valve calcification in hamsters. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Gaopeng Xian, Rong Huang, Minhui Xu, Hengli Zhao, Xingbo Xu, Yangchao Chen, Hao Ren, Dingli Xu, Qingchun Zeng
Noncoding RNA regulates the expression of Krm1 and Dkk2 to synergistically affect aortic valve lesions. Experimental & molecular medicine 56 (7) (2024)
Gaopeng Xian, Rong Huang, Minhui Xu, Hengli Zhao, Xingbo Xu, Yangchao Chen, Hao Ren, Dingli Xu, Qingchun Zeng
Noncoding RNA regulates the expression of Krm1 and Dkk2 to synergistically affect aortic valve lesions. Experimental & molecular medicine 56 (7) (2024)
Xi Yang, Jingxin Zeng, Kaiji Xie, Shuwen Su, Yuyang Guo, Hao Zhang, Jun Chen, Zhuang Ma, Zezhou Xiao, Peng Zhu, Shaoyi Zheng, Dingli Xu, Qingchun Zeng
Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE/NF-κB pathway and exaggerates aortic valve calcification in hamsters. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Gaopeng Xian, Rong Huang, Minhui Xu, Hengli Zhao, Xingbo Xu, Yangchao Chen, Hao Ren, Dingli Xu, Qingchun Zeng
Noncoding RNA regulates the expression of Krm1 and Dkk2 to synergistically affect aortic valve lesions. Experimental & molecular medicine 56 (7) (2024)
Guoheng Zhong, Shuwen Su, Juncong Li, Hengli Zhao, Dongtu Hu, Jun Chen, Shichao Li, Yingwen Lin, Liming Wen, Xiangjie Lin, Gaopeng Xian, Dingli Xu, Qingchun Zeng
Activation of Piezo1 promotes osteogenic differentiation of aortic valve interstitial cell through YAP-dependent glutaminolysis. Science advances 9 (22) (2023)
Shunyi Li, Jianglian She, Jingxin Zeng, Kaiji Xie, Zichao Luo, Shuwen Su, Jun Chen, Gaopeng Xian, Zhendong Cheng, Jing Zhao, Shao-Ping Li, Xingbo Xu, Dingli Xu, Lan Tang, Xue-Feng Zhou, Qingchun Zeng
Marine-Derived Piericidin Diglycoside S18 Alleviates Inflammatory Responses in the Aortic Valve via Interaction with Interleukin 37. Oxidative medicine and cellular longevity 2022 (2022)
Abdul Ghafar Sherzad, Muhibullah Shinwari, M Azim Azimee, Arash Nemat, Qingchun Zeng
Risk Factors for Calcific Aortic Valve Disease in Afghan Population. Vascular health and risk management 18 (2022)
Haobin Zhou, Xianghui Zeng, Yuting Xue, Xiao Wang, Shenrong Liu, Zongyuan Zhu, Zichao Luo, Zhuang Ma, Hao Zhang, Qiong Zhan, Yujia Bai, Xingfu Huang, Qingchun Zeng, Hao Ren, Dingli Xu
Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Nonalcoholic Fatty Liver Disease in Middle Age. The Journal of clinical endocrinology and metabolism 107 (6) (2022)
Qing An, Shuwen Su, Yan Tu, Lingfeng Gao, Gaopeng Xian, Yujia Bai, Qiong Zhan, Xingbo Xu, Dingli Xu, Qingchun Zeng
Efficacy and safety of antithrombotic therapy with non-vitamin K antagonist oral anticoagulants after transcatheter aortic valve replacement: a systematic review and meta-analysis. Therapeutic advances in chronic disease 12 (2021)
Qingchun Zeng, Zhendong Cheng, Yi Xia, Rui Cheng, Ailian Ou, Xinrui Li, Xingbo Xu, Yu-Li Huang, Dingli Xu
Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation. Therapeutic advances in chronic disease 11 (2020)

Qingchun Zeng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qingchun Zeng